ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Oncology Groups Oppose Proposed Cuts In Medicare Payments For Cancer Drugs

October 11, 2002

St. Jude Offers Three Fellowships

May 3, 1985

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs

June 20, 1975

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014